A potential new kidney disease biomarker, suPAR, is causing a big stir in the research community. Previous studies have identified the blood protein as a potential cause of Focal Segmental Glomerulosclerosis, or FSGS. Now a multi-institutional study involving scientists from Rush University, Emory University, Massachusetts General Hospital and Harvard Medical School, NYU Langone Medical Center, … Continue reading Biomarker suPAR Predicts Chronic Kidney Disease
Recently Dr. Richard Glassock participated in an interesting webinar for the International Society of Nephrology. View Dr. Glassock’s webinar to hear him discuss his FSGS axioms, the best approach to evaluate FSGS, and recent research on suPAR as a potential biomarker.
A team of nephrologists and researchers at University of Miami Miller School of Medicine have discovered a factor in the blood that may be responsible for up to two-thirds of the cases of focal segmental glomerulosclerosis or FSGS. They found that an excess of serum soluble urokinase receptor (suPAR) activates a protein in the kidney … Continue reading Researchers Discover Cause of FSGS